SBC Medical Group Holdings Incorporated SBC
Set alert
5.28 USD -0.42 -7.29%
At close · Oct 30
5.28 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
5.24 Day range 5.70
2.87 52-week range 5.69
- YTD
- +22.39%
- 1 year
- +55.60%
- Open
- 5.68
- Prev close
- 5.69
- Mkt cap
- 542.52M
- Vol
- 155.29K
- Avg vol
- 192.03K
- EPS
- 0.47
- P/E
- 11.22
- Div yield
- 0.00%
More statistics
- Low
- 5.24
- High
- 5.70
- Forward P/E
- 0.52
- Beta
- 0.12
- Short ratio
- 0.62
- Inst. own
- 0.29%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 12, 2025
- 50-d avg
- 6.77
- 200-d avg
- 10.90
- 1y target
- 11.00
MAX chart
Events in this range
- Feb 12, 2025Earnings: —; estimate 2.41; surprise —%
Signals (65)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 19, 2026 | 1 week ago |
| RSI: Overbought | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 30, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Feb 16, 2026 | 8 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 8, 2025 | 10 months ago |
| SMA: Bullish | Dec 1, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 20, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| SMA: Bullish | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bearish | Jul 21, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 26, 2025 | 1 year ago |
| SMA: Bullish | May 19, 2025 | 1 year ago |
| SMA: Bearish | Apr 21, 2025 | 1 year ago |
| SMA: Bullish | Apr 7, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 17, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 10, 2025 | 1 year ago |
| RSI: Oversold | Mar 3, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 3, 2025 | 1 year ago |
| RSI: Oversold | Sep 16, 2024 | 2 years ago |
| SMA: Bearish | Aug 26, 2024 | 2 years ago |
| SMA: Bearish | Aug 19, 2024 | 2 years ago |
| SMA: Bullish | Aug 5, 2024 | 2 years ago |
| SMA: Bullish | Aug 5, 2024 | 2 years ago |
| SMA: Bearish | Jul 29, 2024 | 2 years ago |
| SMA: Bearish | Jun 17, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 17, 2024 | 2 years ago |
| SMA: Bullish | Jun 10, 2024 | 2 years ago |
| SMA: Bearish | Jun 3, 2024 | 2 years ago |
| SMA: Bullish | Apr 22, 2024 | 2 years ago |
| RSI: Overbought | Apr 22, 2024 | 2 years ago |
| SMA: Bearish | Apr 8, 2024 | 2 years ago |
| RSI: Overbought | Feb 19, 2024 | 2 years ago |
| RSI: Overbought | Feb 5, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 29, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 1, 2024 | 2 years ago |
| SMA: Bullish | Nov 27, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 27, 2023 | 2 years ago |
| RSI: Overbought | Nov 27, 2023 | 2 years ago |
| MACD: Sell Signal | Nov 13, 2023 | 2 years ago |
| SMA: Bearish | Nov 6, 2023 | 2 years ago |
| RSI: Overbought | Sep 25, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 31, 2023 | 3 years ago |
| SMA: Bullish | Jul 24, 2023 | 3 years ago |
| SMA: Bearish | Jul 10, 2023 | 3 years ago |
| SMA: Bullish | Jun 19, 2023 | 3 years ago |
| SMA: Bearish | May 1, 2023 | 3 years ago |
| SMA: Bearish | May 1, 2023 | 3 years ago |
Financial health
Altman Z-Score
5.04 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A+5 / 5 overall
- DCF 3
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 4
- P/E 4
- P/B 4
Valuation
P/E 8.6×
FY 2022 5y median 18.6× FY 2025
P/S 2.6×
FY 2022 5y median 2.6× FY 2025
P/B 1.8×
FY 2022 5y median 2.3× FY 2025
P/FCF 12.1×
FY 2022 5y median 18.9× FY 2025
EV/EBITDA 3.9×
FY 2022 5y median 4.7× FY 2025
EV/Sales 1.9×
FY 2022 5y median 2.0× FY 2025
FCF Yield 8.2%
FY 2022 5y median 3.5% FY 2025
Profitability
Gross Margin 73.3%
FY 2022 5y median 72.1% FY 2025
Operating Margin 38.9%
FY 2022 5y median 35.4% FY 2025
Net Margin 29.4%
FY 2022 5y median 21.5% FY 2025
ROE 20.5%
FY 2022 5y median 22.2% FY 2025
ROIC 12.6%
FY 2022 5y median 17.0% FY 2025
ROA 13.4%
FY 2022 5y median 14.3% FY 2025
Growth (YoY)
Revenue -15.5%
FY 2022 FY 2025
Operating Income -4.0%
FY 2022 FY 2025
EPS (diluted) 4.2%
FY 2022 FY 2025
Free Cash Flow 112.8%
FY 2022 FY 2025
Financial Health
Current Ratio 3.8×
FY 2022 5y median 2.4× FY 2025
Quick Ratio 3.7×
FY 2022 5y median 2.4× FY 2025
Debt / Equity 0.2×
FY 2022 5y median 0.2× FY 2025
Net Debt / EBITDA -1.3×
FY 2022 5y median -1.3× FY 2025
Interest Coverage 420×
FY 2022 5y median 1100× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31